Absolutely correct. ELLXF has everything going for it: -very low float -revenues doubling over last year -profitable -doing business internationally -huge expansion in US underway -plans to uplist to NYSE or NASDAQ in the works -in the hottest investment sector, HEMP products -a ridiculously low share price of 2.50 -a 'hidden gem', awaiting analyst increased exposure. -a Buy for truly smart investors.
How are those all-you-can-eat 2.50s tasting? At least you used the correct terminology in this post. You can call me a troll if you like but at least we all know to not listen to your advice